Showing 1 - 10 of 11 valve disease

Status: Open Not Enrolling

Investigator: Neal Kleiman

Study Coordinator: Saba Khan

Phone: 713.441.2116

This is a prospective, randomized, parallel-controlled, multicenter clinical evaluation of the MitraClip device for the treatment of clinically significant functional mitral regurgitation in symptomatic subjects too high risk to undergo mitral v ... Read more >

Status: Open Not Enrolling

Investigator: Neal Kleiman

Study Coordinator: LaShawna Green

Phone: 713.441.6548

The study is being done study to obtain data on the safety and performance of the Medtronic CoreValve® System. The Medtronic CoreValve® System has been developed to replace a diseased aortic heart valve without the need for open heart surgery. T ... Read more >

Status: Open Not Enrolling

Investigator: Neal Kleiman

Study Coordinator: LaShawna Green

Phone: 713.441.6548

The purpose of the study is to evaluate the safety and efficacy of the Medtronic CoreValve® System in the treatment of symptomatic severe aortic stenosis in subjects who have a predicted high risk for aortic valve surgery and/or very high risk f ... Read more >

Status: Enrolling

Investigator: Michael Reardon

Study Coordinator: LaShawna Green

Phone: 713.441.6548

The purpose of the study is to evaluate the safety and efficacy of the Medtronic CoreValve® System in the treatment of symptomatic severe aortic stenosis in subjects who have a predicted high risk for aortic valve surgery and/or very high risk f ... Read more >

Status: Enrolling

Investigator: Neal Kleiman

Study Coordinator: Patricia Brinegar

Phone: 713.441.3506

The primary objective of the study is to evaluate the safety and effectiveness of the Medtronic CoreValve® System (MCS) in a subset of subjects excluded from the U.S. Extreme Risk Pivotal Trial population due to one or more additional co-morbidi ... Read more >

Status: Open Not Enrolling

Investigator: Neal Kleiman

Study Coordinator: LaShawna Green

Phone: 713.441.6548

To evaluate the safety and efficacy of the CoreValve Evolut R System in patients with severe symptomatic aortic stenosis who are considered at high through extreme risk for surgical aortic valve replacement ... Read more >

Status: Open Not Enrolling

Investigator: Lisa Kopas

Study Coordinator:

Phone:

The purpose of this research is to study a medical device that is designed to produce lung volume reduction. This device is called the PulmonX Endobronchial Valve (EBV). It has not been approved by the Food and Drug Administration (FDA) and is c ... Read more >

Status: Enrolling

Investigator: Michael Reardon

Study Coordinator:

Phone:

To evaluate the safety and effectiveness of the Model 400 bovine pericardial stented aortic bioprosthesis in a patient population undergoing surgical aortic valve replacement. The collected data will be used to support regulatory applications in ... Read more >

Status: Enrolling

Investigator: Neal Kleiman

Study Coordinator: Patricia Brinegar

Phone: 713.441.3506

The objective of this study is to evaluate the safety and effectiveness of the Lotus™ Valve System for transcatheter aortic valve replacement (TAVR) in symptomatic subjects with calcific, severe native aortic stenosis who are considered at extre ... Read more >

Status: Enrolling

Investigator: Neal Kleiman

Study Coordinator: Patricia Brinegar

Phone: 713.441.3506

The purpose of the study is to investigate the safety and efficacy of transcatheter aortic valve implantation (TAVI) in patients with severe, symptomatic Aortic Stenosis (AS) at intermediate surgical risk by randomizing patients to either Surgic ... Read more >

Status: Enrolling

Investigator: Stephen Little

Study Coordinator: Patricia Brinegar

Phone: 713.441.3506

This study will create a registry of patient data associated with treatment provided at the Methodist DeBakey Heart & Vascular Center Valve Clinic. In the database, details of patients treated at the valve clinic will be entered, including pre-, ... Read more >

Live Chat Available